Steven P. Cohen, Chief of Pain Medicine at Johns Hopkins, Joins Releviate Therapeutics as Head of Its Scientific Advisory Board

SAN DIEGO–(BUSINESS WIRE)–Releviate™ Therapeutics, a bio-pharmaceutical company developing a novel human antibody-based approach to treating neuropathic pain by potentially reversing the underlying pathophysiology of that pain, today appoints Dr. Steven P. Cohen to lead its scientific advisory board. The announcement follows Releviate Therapeutics closing its round of Series A funding. As head of the scientific advisory board, Cohen will provide high-level scientific oversight and lead strate
Click here to view original post